Cotinine and spontaneous abortion: Might variations in metabolism play a role?

Epidemiology

Volumn 17, Issue 5, 2006, Pages 492-494

  Bracken, Michael B ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COTININE; CYTOCHROME P450 1A2; NICOTINE; TOBACCO SMOKE;

ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FEMALE; FETUS DEATH; FIRST TRIMESTER PREGNANCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTRAUTERINE GROWTH RETARDATION; KARYOTYPE; METABOLISM; NOTE; PREMATURE LABOR; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SPONTANEOUS ABORTION;

ABORTION, SPONTANEOUS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); COTININE; CYTOCHROME P-450 CYP1A2; FEMALE; GANGLIONIC STIMULANTS; HUMANS; NICOTINE; PREGNANCY; TOBACCO SMOKE POLLUTION;

EID: 33747104541     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ede.0000229124.49413.d8     Document Type: Note

References (15)

1. US Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta: Centers for Disease Control and Prevention, Office on Smoking and Health; 2004.
2. George L, Granath F, Johansson ALV, et al. Environmental tobacco smoke and risk of spontaneous abortion. Epidemiology. 2006;17:500-505.
3. Sadler L, Belanger K, Saftlas A, et al. Environmental tobacco smoke exposure and small-for-gestational age birth. Am J Epidemiol. 1999;150:695-705.
4. Cashman JR, Park SB, Yang Z-C, et al. Metabolism of nicotine by human liver microsomes: stereoselective formation of trans-nicotine N′-oxide. Chem Res Toxicol. 1992;5:639-646.
5. Grosso LM, Bracken MB. Caffeine metabolism, genetics, and perinatal outcomes: a review of exposure assessment considerations during pregnancy. Ann Epidemiol. 2005;15:460-466.
6. Cnattingius S, Signorello LB, Anneren G, et al. Caffeine intake and the risk of first-trimester spontaneous abortion. N Engl J Med. 2000;343:1839-1845.
7. Benedetti A, Abrahamowicz M. Using generalized additive models to reduce residual confounding. Stat Med. 2004;23:3781-3801.
8. Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev. 1996;18:188-204.
9. Signorello LB, Nordmark A, Granath F, et al. Caffeine metabolism and the risk of spontaneous abortion of normal karyotype fetuses. Obstet Gynecol. 2001;98:1059-1066.
10. Nakajima M, Iwata K, Yamamoto T, et al. Nicotine metabolism in liver microsomes from rats with acute hepatitis or cirrhosis. Drug Metab Dispos. 1998;26:36-41.
11. O'Connor TZ, Holford TR, Leaderer BP, et al. Measurement of exposure to environmental tobacco smoke in pregnant women. Am J Epidemiol. 1995;142:1315-1321.
12. Grosso LM, Triche EW, Belanger K, et al. Caffeine metabolites in umbilical cord blood, cytochrome P-450 1A2 activity, and intrauterine growth restriction. Am J Epidemiol. 2006;163:1035-1041.
13. Pavanello S, Simioli P, Lupi S, et al. Exposure levels and cytochrome P450 1A2 activity, but not N-acetyltransferase, glutathione S-transferase (GST) M1 and T1, influence urinary mutagen excretion in smokers. Cancer Epidemiol Biomarkers Prev. 2002;11:998-1003.
14. Pavanello S, Pulliero A, Lupi S, et al. Influence of the genetic polymorphism in the 5′-noncoding region of the CYP1A2 gene on CYP1A2 phenotype and urinary mutagenicity in smokers. Mutat Res. 2005;587:59-66.
15. Bartsch H, Nair U, Risch A, et al. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev. 2000;9:3-28.